SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2022, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2022 is Rs. -9.57 millions as compared to Net Loss of Rs. -6.33 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 further decreased to -3.34% as compared to -2.16% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 1.09 0.00 0.00 3.94 0.00 3.95 12.66 -68.80
Other Income 0.00 -0.57 0.00 0.00 -1.33 0.00 1.66 1.95 -14.87
PBIDT -3.34 -2.16 54.63 -6.85 -10.33 -33.69 -10.46 -15.35 -31.86
Interest 3.97 2.60 52.69 8.92 6.05 47.44 9.00 15.49 -41.90
PBDT -7.31 -4.76 53.57 -15.77 -16.38 -3.72 -19.46 -30.84 -36.90
Depreciation 1.54 1.52 1.32 4.62 4.63 -0.22 6.16 7.28 -15.38
PBT -8.85 -6.28 40.92 -20.39 -21.01 -2.95 -25.62 -38.12 -32.79
TAX 0.72 0.05 1340.00 -2.51 8.40 -129.88 -17.29 -18.03 -4.10
Deferred Tax 0.72 0.05 1340.00 -2.51 8.40 -129.88 -17.29 -18.03 -4.10
PAT -9.57 -6.33 51.18 -17.88 -29.41 -39.20 -8.33 -20.09 -58.54
Equity 73.59 73.59 0.00 73.59 73.59 0.00 73.59 73.59 0.00
PBIDTM(%) 0.00 -198.17 0.00 0.00 -262.18 0.00 -264.81 -121.25 118.40

Vista Pharma Share Price

8.03 0.33 (4.29%)
24-Apr-2026 10:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.95
Dr. Reddys Lab 1317.90
Cipla 1287.20
Zydus Lifesciences 929.75
Lupin 2294.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×